Treatment of lupus erythematosus with fumaric acid ester derivatives: two case-reports

Abstract

Introduction Fumaric acid ester derivatives, or fumarates, have immunomodulating properties [1]. For over four decades fumarates have been applied in the treatment of psoriasis with proven efficacy and long-term safety [2,3]. More recently, fumarates have been assessed in multiple sclerosis [4]. Given their favorable safety-profile, fumarates could be of value in the treatment of other immune-mediated inflammatory diseases.

DOI: 10.1186/1479-5876-9-S2-P15

Extracted Key Phrases

05020162017
Citations per Year

Citation Velocity: 16

Averaging 16 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@inproceedings{Balak2011TreatmentOL, title={Treatment of lupus erythematosus with fumaric acid ester derivatives: two case-reports}, author={Deepak M. W. Balak and Hok Bing Thio}, booktitle={Journal of Translational Medicine}, year={2011} }